SMOC
08 Jun 2021
SMOC+
ACTRN12613000987763
A surveillance study utilizing whole body magnetic resonance imaging and other surveillance procedures in people with germ line cancer gene mutations to investigate the prevalence and incidence of investigable lesions.
ASS/Garvan
Cancer Type | All cancers |
---|---|
Trial Type | Early detection, diagnosis, prognosis |
Phase | - |
Age Range | 18 years and older |
Sex | All |
Tumour Stream | - |
Cancer Stage | - |
Anticipated Start Date | 2013-06-09 |
Anticipated End Date | 2026-09-01 |
Hospital | Royal Adelaide Hospital |
---|---|
Clinical Trial Coordinator | Anne Milton |
anne.milton@sa.gov.au | |
Phone | 08 7074 2342 |
Principal Investigator | Professor Michael Brown |
Recruitment Status | Recruiting |
Keep up to date with the latest news and breakthroughs